Transition Bio

Cambridge, MA · Founded 2020 · Privately Held (backing)

Operator of a biotechnology company intended to build a hypothesis-free drug discovery and diagnostics platform for human health care advancement. Transition Bio is based in Cambridge, MA and was founded in 2020. Its last known valuation is $26.8 million. It has raised $76.5 million across 3 recorded rounds; the latest was a $13.3 million early-stage round in Oct 2024.

Last price · $/share
—
Implied valuation
$26.8M
Total raised
$76.5M
Last round
Early Stage VC
Oct 2024
How much has Transition Bio raised?
$76.5Macross 3 recorded rounds · Mar 2022 – Oct 2024

Most recently, Transition Bio raised $13.3M in its Early Stage VC (Oct 2024).

Free account
More of Transition Bio with a free account
  • ·Watch Transition Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Transition Bio round by round

3 rounds
Oct 2024Early Stage VC$13.3MSEC filing▮
8 investors participated
Dec 2023Early Stage VC$6.0MSEC filing▮
5 investors participated
Mar 2022Early Stage VC$39.1MSEC filing▮
22 investors participated

How much has Transition Bio raised?

Transition Bio has raised $76.5 million across 3 recorded rounds since 2022. The largest was a $6 million early-stage round in Dec 2023; the most recent was a $13.3 million early-stage round in Oct 2024.

Transition Bio has filed 4 Form Ds with the SEC since 2022, most recently in Oct 2024 ($13.3 million sold to 8 investors).

Transition Bio investors

6 investors are on record for Transition Bio, including Bristol-Myers Squibb, Lifeforce Capital, Magnetic Ventures and Northpond Ventures. The early-stage round in Oct 2024 drew 8 investors.

For fundraisers
Raising for a company like Transition Bio?

6 investors have backed Transition Bio.

See all 6 investors →

Frequently asked about Transition Bio

How much has Transition Bio raised?
Transition Bio has raised $76.5M in total across 3 recorded funding rounds.
When was Transition Bio's last funding round?
Transition Bio's most recent recorded round was Early Stage VC in Oct 2024, raising $13.3M.